PT821006E - Derivados de insulina com ligacao a zinco aumentada - Google Patents

Derivados de insulina com ligacao a zinco aumentada

Info

Publication number
PT821006E
PT821006E PT97112197T PT97112197T PT821006E PT 821006 E PT821006 E PT 821006E PT 97112197 T PT97112197 T PT 97112197T PT 97112197 T PT97112197 T PT 97112197T PT 821006 E PT821006 E PT 821006E
Authority
PT
Portugal
Prior art keywords
insulin derivatives
enhanced zinc
link
zinc link
enhanced
Prior art date
Application number
PT97112197T
Other languages
English (en)
Inventor
Gerhard Seipke
Karl Geisen
Habermann Dr Paul
Johann Ertl
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT821006E publication Critical patent/PT821006E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97112197T 1996-07-26 1997-07-17 Derivados de insulina com ligacao a zinco aumentada PT821006E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19630242 1996-07-26

Publications (1)

Publication Number Publication Date
PT821006E true PT821006E (pt) 2004-09-30

Family

ID=7800962

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97112197T PT821006E (pt) 1996-07-26 1997-07-17 Derivados de insulina com ligacao a zinco aumentada

Country Status (25)

Country Link
US (1) US6221837B1 (pt)
EP (1) EP0821006B1 (pt)
JP (1) JP4046388B2 (pt)
KR (1) KR100547922B1 (pt)
CN (2) CN1158305C (pt)
AR (1) AR008269A1 (pt)
AT (1) ATE264871T1 (pt)
AU (1) AU725201B2 (pt)
BR (1) BR9704117B1 (pt)
CA (1) CA2207078C (pt)
CZ (1) CZ292274B6 (pt)
DE (1) DE59711533D1 (pt)
DK (1) DK0821006T3 (pt)
ES (1) ES2218622T3 (pt)
HK (1) HK1048125A1 (pt)
HU (1) HU224591B1 (pt)
IL (2) IL121381A (pt)
NO (1) NO317666B1 (pt)
NZ (1) NZ328421A (pt)
PL (1) PL188617B1 (pt)
PT (1) PT821006E (pt)
RU (1) RU2176646C2 (pt)
TR (1) TR199700685A3 (pt)
TW (1) TW474944B (pt)
ZA (1) ZA976645B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
DE19947456A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
US7238663B2 (en) * 2001-08-28 2007-07-03 Eli Lilly And Company Pre-mixes of GLP-1 and basal insulin
US7179788B2 (en) * 2001-10-19 2007-02-20 Eli Lilly And Company Biphasic mixtures of GLP-1 and insulin
KR100769183B1 (ko) * 2001-12-28 2007-10-23 엘지.필립스 엘시디 주식회사 면발광 램프
WO2004096854A2 (en) * 2003-04-29 2004-11-11 Eli Lilly And Company Insulin analogs having protracted time action
EP2107069B1 (en) * 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
NZ553263A (en) * 2004-07-19 2010-06-25 Biocon Ltd Insulin-oligomer conjugates, formulations and uses thereof
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
ES2371361T3 (es) 2005-12-28 2011-12-30 Novo Nordisk A/S Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones.
CN101573133B (zh) * 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
JP5864834B2 (ja) * 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー/エス プロテアーゼ耐性のインスリンアナログ
EP2152245B1 (en) * 2007-04-30 2015-12-02 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
AU2008257505B2 (en) * 2007-06-01 2013-05-16 Novo Nordisk A/S Stable non-aqueous pharmaceutical compositions
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー/エス インスリン誘導体を含有する薬学的製剤
US9241908B2 (en) * 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
EP2254905B1 (en) * 2008-03-14 2016-12-14 Novo Nordisk A/S Protease-stabilized insulin analogues
EP2910570B1 (en) 2008-03-18 2016-10-12 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US9603904B2 (en) * 2008-10-30 2017-03-28 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー/エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
ES2594303T3 (es) 2012-04-11 2016-12-19 Novo Nordisk A/S Formulaciones de insulina
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
MX366636B (es) 2013-10-07 2019-07-17 Novo Nordisk As Nuevo derivado de un análogo de insulina.
FR3013049B1 (fr) 2013-11-14 2015-11-13 You-Ping Chan Analogue de l'insuline glargine
US20180169190A1 (en) 2016-12-16 2018-06-21 Novo Nordisk A/S Insulin containing pharmaceutical compositions
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
DE3326472A1 (de) 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3440988A1 (de) 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
US4569794A (en) 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DE3526995A1 (de) 1985-07-27 1987-02-05 Hoechst Ag Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
DE3636903A1 (de) 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
DE3541856A1 (de) 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
DE3805150A1 (de) 1987-04-11 1988-10-20 Hoechst Ag Gentechnologisches verfahren zur herstellung von polypeptiden
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE3739347A1 (de) 1987-11-20 1989-06-01 Hoechst Ag Verfahren zur selektiven spaltung von fusionsproteinen
ES2061797T3 (es) 1988-06-23 1994-12-16 Hoechst Ag Mini-proinsulina, su preparacion y empleo.
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
DE3921447A1 (de) * 1989-06-30 1991-01-17 Hoechst Ag Verfahren zur herstellung von n-alkyl-halogenanilinen
US5227293A (en) 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
US5358857A (en) 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
GR1005153B (el) 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
ZA928916B (en) * 1991-11-26 1994-05-18 Lilly Co Eli Tri-arginine insulins
DK0600372T3 (da) 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
DE4405179A1 (de) 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
EP0771208B1 (en) * 1994-08-12 2005-10-19 Immunomedics, Inc. Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells

Also Published As

Publication number Publication date
ZA976645B (en) 1998-01-26
AR008269A1 (es) 1999-12-29
MX9705667A (es) 1998-07-31
CZ292274B6 (cs) 2003-08-13
US6221837B1 (en) 2001-04-24
NO973438L (no) 1998-01-27
CN1362417A (zh) 2002-08-07
NO973438D0 (no) 1997-07-25
BR9704117A (pt) 1998-12-29
CZ237097A3 (cs) 1998-02-18
DK0821006T3 (da) 2004-08-16
IL121382A0 (en) 1998-01-04
BR9704117B1 (pt) 2009-08-11
IL121381A (en) 2004-09-27
HU224591B1 (hu) 2005-11-28
NO317666B1 (no) 2004-11-29
CN1158305C (zh) 2004-07-21
KR980009281A (ko) 1998-04-30
JPH1072496A (ja) 1998-03-17
CA2207078A1 (en) 1998-01-26
CA2207078C (en) 2008-01-29
IL121381A0 (en) 1998-01-04
KR100547922B1 (ko) 2006-06-22
EP0821006B1 (de) 2004-04-21
EP0821006A3 (de) 2001-11-28
HU9701299D0 (en) 1997-09-29
TW474944B (en) 2002-02-01
HUP9701299A1 (hu) 1998-11-30
PL321343A1 (en) 1998-02-02
AU3017197A (en) 1998-02-05
JP4046388B2 (ja) 2008-02-13
PL188617B1 (pl) 2005-03-31
ES2218622T3 (es) 2004-11-16
TR199700685A2 (xx) 1998-02-21
TR199700685A3 (tr) 1998-02-21
HK1048125A1 (zh) 2003-03-21
EP0821006A2 (de) 1998-01-28
RU2176646C2 (ru) 2001-12-10
DE59711533D1 (de) 2004-05-27
HUP9701299A3 (en) 2001-04-28
ATE264871T1 (de) 2004-05-15
NZ328421A (en) 1998-12-23
CN1172811A (zh) 1998-02-11
AU725201B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
PT821006E (pt) Derivados de insulina com ligacao a zinco aumentada
DK0988310T3 (da) 4"-substituerede 9-deoxo-9a-aza-9a-homoerythromycin A-derivater
NO2006014I1 (no) Insulin glulisin
NO994071D0 (no) Epotilones med en modifisert sidekjede
HUP9800523A3 (en) Insulin derivatives
DE69812568D1 (de) Verbinder mit Abdeckung
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
PT887320E (pt) Vidro verde-escuro sodo-calcico
DE59609011D1 (de) Polycaprolactam mit neuartiger kettenregelung
DE69528882T2 (de) Batteriefördervorrichtung
FR2768046B1 (fr) Cotyle a bouchons
FR2758387B1 (fr) Four-tunnel a elements infra-rouge
DE29720506U1 (de) Armbanduhr mit zweiteiligem Gehäuse
FR2744612B1 (fr) Couperet a oursins
KR970052087U (ko) 유아용 문을 내장한 문
KR940021680U (ko) 광고문을 실은 담배
DE29721448U1 (de) Spritze mit Sicherheitsabdeckung
FR2735533B3 (fr) Turbine de forage a demultiplicateur
FR2772418B1 (fr) Survitrage a charnieres invisibles
DE29716835U1 (de) Kerzenlicht mit Sicherheitsumhüllung
BR7702022U (pt) Contador de vagões
GB9624004D0 (en) Cigarette with a light
DE29714082U1 (de) Montageanordnung mit Sicherungsring
DE9414068U1 (de) Laubstecher mit transportschützender Verlängerung
DE29513587U1 (de) Multibox mit Teilkammern